 DNB Asset Management AS bought a new position in Coherus Biosciences Inc NASDAQ:CHRS in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 17,817 shares of the biotechnology companys stock, valued at approximately 318,000. Several other institutional investors and hedge funds ... 